Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Sale to Cover Tax Obligations

Kevin Feeley, CFO of GeneDx Holdings Corp., sold 895 shares of Class A Common Stock on September 9, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On September 9, 2024, Kevin Feeley, the CFO of GeneDx Holdings Corp., engaged in transactions involving the company's Class A Common Stock.
• Feeley acquired 2,462 shares through the vesting of restricted stock units (RSUs) at no cost.
• Simultaneously, Feeley sold 895 shares at a price of $33.33 per share.
• This sale was executed to cover tax withholding obligations associated with the RSU vesting.
• Following these transactions, Feeley directly owns 39,910 shares of Class A Common Stock and 22,159 restricted stock units.
• The RSUs vest in quarterly installments over a 4-year period starting March 9, 2023, contingent upon continued service to the Issuer.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and tax obligations, without indicating any significant positive or negative developments for the company.

Positives

• The vesting of RSUs indicates a form of compensation and alignment of the CFO's interests with the company's performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily relate to executive compensation and tax obligations.

Key Dates